Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 2
2005 5
2006 5
2007 4
2008 5
2009 6
2010 10
2011 10
2012 13
2013 12
2014 12
2015 10
2016 6
2017 8
2018 8
2019 5
2020 7
2021 8
2022 6
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Oral Colchicine and Low-Dose Aspirin Combination Therapy for Non-elderly, Non-severe, Early Time From Onset, Adult Outpatients with Coronavirus Disease 2019 (COVID-19) during "The Fifth Pandemic Wave" in Japan.
Inokuchi T, Homma T, Kitasato Y, Akiyama M, Chikasue A, Nishii Y, Ban S, Adachi T, Sonezaki A, Masuda H, Kamei H, Takenaka M, Tanaka M, Okamoto M, Hoshino T; K-COCOA (KURUME-COVID-19 THERAPEUTIC PROGRAM BY COLCHICINE AND LOW-DOSE ASPIRIN) STUDY COLLABORATORS. Inokuchi T, et al. Among authors: tanaka m. Kurume Med J. 2024 Mar 19. doi: 10.2739/kurumemedj.MS7012003. Online ahead of print. Kurume Med J. 2024. PMID: 38508737 Free article.
STING activator 2'3'-cGAMP enhanced HSV-1-based oncolytic viral therapy.
Sibal PA, Matsumura S, Ichinose T, Bustos-Villalobos I, Morimoto D, Eissa IR, Abdelmoneim M, Aboalela MAM, Mukoyama N, Tanaka M, Naoe Y, Kasuya H. Sibal PA, et al. Among authors: tanaka m. Mol Oncol. 2024 Feb 23. doi: 10.1002/1878-0261.13603. Online ahead of print. Mol Oncol. 2024. PMID: 38400597 Free article.
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial.
Iwase T, Saji S, Iijima K, Higaki K, Ohtani S, Sato Y, Hozumi Y, Hasegawa Y, Yanagita Y, Takei H, Tanaka M, Masuoka H, Tanabe M, Egawa C, Komoike Y, Nakamura T, Ohtsu H, Mukai H. Iwase T, et al. Among authors: tanaka m. J Clin Oncol. 2023 Jun 20;41(18):3329-3338. doi: 10.1200/JCO.22.00577. Epub 2023 Apr 20. J Clin Oncol. 2023. PMID: 37079878 Clinical Trial.
Histopathology of non-mass-like breast lesions on ultrasound.
Yamaguchi R, Watanabe H, Mihara Y, Yamaguchi M, Tanaka M. Yamaguchi R, et al. Among authors: tanaka m. J Med Ultrason (2001). 2023 Jul;50(3):375-380. doi: 10.1007/s10396-023-01286-y. Epub 2023 Feb 11. J Med Ultrason (2001). 2023. PMID: 36773105 Free PMC article. Review.
135 results